Search

Author/Creator Wyles, David L.

1. All‐oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment‐naïve patients with genotype 1 HCV infection. Issue 1 (28th May 2014)

Authors:
Wyles, David L.; Rodriguez‐Torres, Maribel; Lawitz, Eric; Shiffman, Mitchell L.; Pol, Stanislas; Herring, Robert W.; Massetto, Benedetta; Kanwar, Bittoo; Trenkle, James D.; Pang, Phil S.; Zhu, Yanni; Mo, Hongmei; Brainard, Diana M.; Subramanian, G. Mani; McHutchison, John G.; Habersetzer, Françoi...
Journal:
Hepatology
Issue:
Volume 60:Issue 1(2014:Jul.)
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis. Issue 3 (11th December 2018)

Authors:
Flamm, Steven; Mutimer, David; Asatryan, Armen; Wang, Stanley; Rockstroh, Jürgen; Horsmans, Yves; Kwo, Paul Y.; Weiland, Ola; Villa, Erica; Heo, Jeong; Gane, Edward; Ryder, Stephen D.; Welzel, Tania M.; Ruane, Peter J.; Agarwal, Kosh; Ng, Teresa I.; Xue, Zhenyi; Lovell, Sandra S.; Krishnan, Preet...
Journal:
Journal of viral hepatitis
Issue:
Volume 26:Issue 3(2019)
Page Start:
337
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Issue 3 (4th August 2015)

Authors:
AASLD/IDSA HCV Guidance Panel; Chung, Raymond T.; Davis, Gary L.; Jensen, Donald M.; Masur, Henry; Saag, Michael S.; Thomas, David L.; Aronsohn, Andrew I.; Charlton, Michael R.; Feld, Jordan J.; Fontana, Robert J.; Ghany, Marc G.; Godofsky, Eliot W.; Graham, Camilla S.; Kim, Arthur Y.; Kiser, Jen...
Journal:
Hepatology
Issue:
Volume 62:Issue 3(2015:Sep.)
Page Start:
932
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non‐adherence. Issue 12 (30th April 2020)

Authors:
Sulkowski, Mark; Luetkemeyer, Annie F.; Wyles, David L.; Martorell, Claudia; Muir, Andrew; Weisberg, Ilan; Gordon, Stuart C.; McLain, Richard; Huhn, Gregory
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 12(2020)
Page Start:
1384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s. Issue 1 (12th December 2019)

Authors:
Venuto, Charles S.; Cramer, Yoninah S.; Rosenkranz, Susan L.; Sulkowski, Mark; Wyles, David L.; Cohen, Daniel E.; Schmidt, Jeffrey; Alston‐Smith, Beverly L.; Morse, Gene D.
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 1(2020)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection. Issue 4 (22nd August 2015)

Authors:
Carlin, Aaron F.; Aristizabal, Paula; Song, Qinghua; Wang, Huan; Paulson, Matthew S.; Stamm, Luisa M.; Schooley, Robert T.; Wyles, David L.
Journal:
Hepatology
Issue:
Volume 62:Issue 4(2015:Oct.)
Page Start:
1047
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗